Worker Remittances and Capital Flows to Developing Countries

Worker remittances constitute an increasingly important mechanism for the transfer of resources from developed to developing countries, and remittances are the second-largest source, behind foreign direct investment, of external funding for developing countries. Yet, literature on worker remittances has so far focused mainly on the impact of remittances on income distribution within countries, on the determinants of remittances at a micro-level, or on the effects of migration and remittances for specific countries or regions. The focus of this paper is thus on four questions: First, how important are worker remittances to developing countries in quantitative terms? Second, what are the determinants driving worker remittances? Third, how volatile are worker remittances to developing countries? Fourth, are remittances correlated to other capital flows? --remittances,capital flows,developing countries

Worker Remittances and Capital Flows to Developing Countries

Worker remittances constitute an increasingly important mechanism for the transfer of resources from developed to developing countries, and remittances are the second-largest source, behind foreign direct investment, of external funding for developing countries. Yet, literature on worker remittances has so far focused mainly on the impact of remittances on income distribution within countries, on the determinants of remittances at a micro-level, or on the effects of migration and remittances for specific countries or regions. The focus of this paper is thus on four questions: First, how important are worker remittances to developing countries in quantitative terms? Second, what are the determinants driving worker remittances? Third, how volatile are worker remittances to developing countries? Fourth, are remittances correlated to other capital flows

2nd AtlantOS progress report plus International Scientific and Technical Advisory Board minutes and AtlantOS Legacy document

Prior to the 3rd annual meeting in month 32 a project progress report for the external project boards will be prepared to enable them to as good as possible prepared for the meeting and to ensure consequently that AtlantOS receives as constructive as possible recommendations from the board. The report together with the external summary board meeting report will be part of D11.

Everything at a glance: BAföG - Student Housing - Student Dining Counseling - Social Affairs Culture - International Affairs

Das Studentenwerk Dresden unterstützt die Studierenden als Anstalt des öffentlichen Rechts mit seinen umfangreichen Service-Angeboten ca. 40.000 Studierende von sieben Hochschulen und einer Berufsakademie an den Standorten Dresden, Tharandt, Zittau und Görlitz

Alles auf einen Blick: BAföG, Wohnen, Mensa, Beratung, Soziales, Kultur, Internationales

Das Studentenwerk Dresden unterstützt die Studierenden als Anstalt des öffentlichen Rechts mit seinen umfangreichen Service-Angeboten ca. 40.000 Studierende von sieben Hochschulen und einer Berufsakademie an den Standorten Dresden, Tharandt, Zittau und Görlitz

Fritz-Löffler-Straße 16/18

Zwischen 1953 und 1955 wurde nach Plänen Wolfgang Raudas an der heutigen Fritz-Löffler-Straße 16-18 eines der ersten Dresdner Studentenwohnheime errichtet. Das Besondere an diesem Bau ist das Ausmaß der künstlerischen Gestaltung. Die Fassade ist durch Erker gegliedert, welche zwischen 1954 und 1955 jeweils durch einen Bildhauer mit Sandsteinreliefs verziert wurden. Im Inneren arbeiteten Künstler zeitgleich zusammen mit Studenten an einigen Gipsschnitten und fast 70 Wandmalereien, welche leider nicht alle erhalten geblieben sind

Standorte: Fritz-Löffler-Straße 12, Hochschulstraße 46-50

Die Dresdner Wohnheime wurden im Laufe der Zeit reich mit unterschiedlichen Kunstwerken ausgestattet – mit Skulpturen, Wandbildern, Sgraffitis bis hin zu Glasbildern. In dieser Ausgabe werden Wohnheime vorgestellt, die bereits in Plattenbauweise errichtet wurden, sodass eine Anbringung von Reliefs oder Wandbildern direkt am Gebäude baulich oft nicht mehr möglich oder wie im Fall der Punkthochhäuser an der Hochschulstraße ästhetisch kaum sinnvoll war. Deshalb entschied man sich hier für Kunstwerke außerhalb der Gebäude – Skulpturen, die zwischen ihnen im halböffentlichen Raum auf die Bewohner wirken

Association of acute Babesia canis infection and serum lipid, lipoprotein, and apoprotein concentrations in dogs

Background Babesia canis infection induces a marked acute phase response (APR) that might be associated with alteration in lipid and lipoprotein metabolism and disease prognosis. Hypothesis Dogs with B. canis-induced APR develop dyslipidemia with altered lipoprotein concentration and morphology. Animals Twenty-nine client-owned dogs with acute B. canis infection and 10 clinically healthy control dogs. Methods Observational cross-sectional study. Serum amyloid A (SAA) was measured using ELISA. Cholesterol, phospholipids, and triglycerides were determined biochemically. Lipoproteins were separated using agarose gel electrophoresis. Lipoprotein diameter was assessed by polyacrylamide gradient gel electrophoresis; correlation with ApoA-1 (radioimmunoassay) and SAA was determined. Results Dogs with B. canis infection had a marked APR (median SAA, 168.3 mu g/mL; range, 98.1-716.2 mu g/mL) compared with controls (3.2 mu g/mL, 2.0-4.2 mu g/mL) (P < .001). Dogs with B. canis infection had significantly lower median cholesterol (4.79 mmol/L, 1.89-7.64 mmol/L versus 6.15 mmol/L, 4.2-7.4 mmol/L) (P = .02), phospholipid (4.64 mmol/L, 2.6-6.6 mmol/L versus 5.72 mmol/L, 4.68-7.0 mmol/L) (P = .02), and alpha-lipoproteins (77.5%, 27.7%-93.5% versus 89.2%, 75.1%-93.5%) (P = .04), and higher ApoA-1 (1.36 U, 0.8-2.56 U versus 0.95 U, 0.73-1.54 U) concentrations (P = .02). Serum amyloid A correlated with high-density lipoproteins (HDLs) diameter (rho = .43; P = .03) and ApoA-1 (rho = .63, P < .001). Conclusions and Clinical Importance Major changes associated with B. canis-induced APR in dogs are related to concentration, composition, and morphology of HDL particles pointing to an altered reverse cholesterol transport. Parallel ApoA-1 and SAA concentration increase is a unique still unexplained pathophysiological finding

EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2019 update

Objectives: To provide an update of the European League Against Rheumatism (EULAR) rheumatoid arthritis (RA) management recommendations to account for the most recent developments in the field. Methods: An international task force considered new evidence supporting or contradicting previous recommendations and novel therapies and strategic insights based on two systematic literature searches on efficacy and safety of disease-modifying antirheumatic drugs (DMARDs) since the last update (2016) until 2019. A predefined voting process was applied, current levels of evidence and strengths of recommendation were assigned and participants ultimately voted independently on their level of agreement with each of the items. Results: The task force agreed on 5 overarching principles and 12 recommendations concerning use of conventional synthetic (cs) DMARDs (methotrexate (MTX), leflunomide, sulfasalazine); glucocorticoids (GCs); biological (b) DMARDs (tumour necrosis factor inhibitors (adalimumab, certolizumab pegol, etanercept, golimumab, infliximab), abatacept, rituximab, tocilizumab, sarilumab and biosimilar (bs) DMARDs) and targeted synthetic (ts) DMARDs (the Janus kinase (JAK) inhibitors tofacitinib, baricitinib, filgotinib, upadacitinib). Guidance on monotherapy, combination therapy, treatment strategies (treat-to-target) and tapering on sustained clinical remission is provided. Cost and sequencing of b/tsDMARDs are addressed. Initially, MTX plus GCs and upon insufficient response to this therapy within 3 to 6 months, stratification according to risk factors is recommended. With poor prognostic factors (presence of autoantibodies, high disease activity, early erosions or failure of two csDMARDs), any bDMARD or JAK inhibitor should be added to the csDMARD. If this fails, any other bDMARD (from another or the same class) or tsDMARD is recommended. On sustained remission, DMARDs may be tapered, but not be stopped. Levels of evidence and levels of agreement were mostly high. Conclusions: These updated EULAR recommendations provide consensus on the management of RA with respect to benefit, safety, preferences and cost